The engineers of new biomaterials, including those used in aesthetic and reconstructive
surgery, strive to develop implantable materials that are capable of producing a specific host
tissue response. Advances in surface science instrumentation over the last 30 years have
allowed bioengineers to evaluate the molecular events occurring at the biomaterial host
interface. The early innovations in breast implant surface technology were focused on
reducing device failure and gel bleed. 1 One of the leading drivers in the development of …